Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Management of chronic asthma Age: Adults |
Dose: Inhalation – 100-400 mcg Frequency: twice daily Note: When patient's symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained. |
|
Indication: Prophylaxis of asthma Age: Adults |
Dose: Inhalation – 50-200 mcg Frequency: twice daily Note: Increased if necessary to maximum 400 mcg twice daily. When patient's symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Management of chronic asthma Age: Children over 12 years |
Dose: Inhalation – 100-400 mcg Frequency: twice daily Note: When patient's symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained. |
|
Indication: Management of chronic asthma Age: Children (5-12 years) |
Dose: Inhalation – 100-200 mcg Frequency: twice daily Note: When patient's symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained. Maximum dose is 200-400 mcg twice daily. |
Administration
- Shake well before use
- Prime inhaler first
Side Effect
- Pharyngitis (5-27%)
- Headache (8-25%)
- URI (5-11%)
- Rhinitis (3-7%)
- Pain (1-5%)
- Increased asthma symptoms (2-4%)
- Dysphonia (1-4%)
- Sinusitis (3%)
- Oral symptoms (2-3%)
- Nausea (1-2%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 inhibitors
|
Increased plasma concentrations
|
|
CYP3A4 inducers
|
Decreased plasma concentrations
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
The Inhaler should be stored below 30° C, protected from direct sunlight and heat. The canister should not be broken, punctured or burnt, even when apparently empty. Keep away from eyes. Keep out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.